Frank Muhlenbeck Net Worth

What's Frank Muhlenbeck's mailing address?

Frank's mailing address filed with the SEC is C/O CONFORMIS, INC., 28 CROSBY DRIVE, BEDFORD, MA, 01730.

Insiders trading at Conformis

Over the last 9 years, insiders at Conformis have traded over $10,769,806 worth of Conformis stock and bought 583,200 units worth $267,840 . The most active insiders traders include Capital Management Llcchris..., Philipp Lang et Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of $122,083. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth $10,302.

What does Conformis do?

our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h

Conformis executives and stock owners

Conformis executives and other stock owners filed with the SEC include:

• Mark Augusti,
  President, Chief Executive Officer, Director
• Mark A. Augusti,
  CEO, Pres & Director
• Robert S Howe,
  CFO & Treasurer
• J. Brent Alldredge J.D.,
  Corp. Sec.
• J. Brent Alldredge,
  Chief Legal Officer and Corporate Secretary
• Michael Milligan,
  Independent Director
• Richard Meelia,
  Independent Director
• Bradley Langdale,
  Independent Director
• Philip Johnston,
  Independent Director
• Carrie Bienkowski,
  Director
• Gary Maingot,
  Senior Vice President - Operations
• Robert Howe,
  Chief Financial Officer, Treasurer
• Kenneth Fallon,
  Independent Chairman of the Board
• Denise E. Pedulla J.D., M.P.H.,
  Chief Legal Officer & Corp. Sec.
• Michael Fillion,
  Chief Operating Officer
• Erin Henry,
  Corp. Controller
• Terrance Wong,
  Sr. VP of HIP & Private Label Engineering
• Eric Rickenbach,
  Sr. VP of US Sales
• Allison Baker,
  Director of HR
• Farzin Khaghani,
  VP of U.S. Marketing
• John Slamin,
  Chief Technology Officer
• Daniel Steines,
  Chief Technology Officer
• Robert Iii Law,
  Senior Vice President, Sales
• Philipp Lang,
  President & C.E.O.
• Paul S Weiner,
  Chief Financial Officer
• David Cerveny,
  Chief Legal Off & G. Counsel
• Denise E Pedulla,
  FORMER CLO & SECRETARY
• Erin Henry,
  CORP CONTROLLER & INTERIM PAO
• Christine Desrochers,
  Fmr Interim CFO & Controller
• Capital Management Llcchris...,
  
• Patricia A Davis,
  CLO & GENERAL COUNSEL
• Dhabi Investment Authority ...,
  
• Frank Muhlenbeck,
  Director
• Laurent Souviron,
  Director
• Gary P Fischetti,